The FDA would provide manufacturers with appropriate time to either reformulate drugs containing oral phenylephrine or remove ...

Opening higher at ₹575.95 apiece on the BSE, shares of Granules India Ltd. rose further to touch an intraday high of ₹590.

Global pharma major Lupin Limited on Friday announced that it has received tentative approval from the United States Food and ...

The inspection, which took place in September, determined that the facility is in compliance with all applicable USFDA ...

Six types of brie cheese sold at Aldi stores in New Jersey and 11 other states have been recalled due to possible listeria ...

Granules India announced that it has received an establishment inspection report (EIR) from the U.S. Food and Drug Administration (USFDA) for its Unit V facility located at Jawaharlal Nehru Pharma ...

Dr Reddy's Laboratories is recalling over 3.3 lakh bottles of a medication used to treat high calcium levels in the blood and ...

Irvine: Johnson & Johnson MedTech has announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE Platform ...

Following the United States Food and Drug Administration’s (USFDA) designation of its Goa plant inspection as Voluntary ...

Biocon Biologics' Bengaluru drug substance facility has been classified as voluntary action indicated by the USFDA following ...

Shares of Cipla gained nearly 2 per cent on Monday, following the United States Food and Drug Administration (USFDA) classifying its Goa facility as “Voluntary Action Indicated” (VAI) status.

Cipla Ltd. shares jumped over 10% in early trade on Thursday after the USFDA classified its Goa facility as “Voluntary Action ...